Maternal and perinatal outcome in Rh negative mothers


  • Rashmi Tripathi Department of Obstetrics and Gynecology, J. K. Hospital and L. N. Medical College, Bhopal, Madhya Pradesh, India
  • Neelam Singh Department of Obstetrics and Gynecology, J. K. Hospital and L. N. Medical College, Bhopal, Madhya Pradesh, India



Hydrops foetalis, Isoimmunization, Immuunoprophylaxis


Background: The objective of this study is to find out the incidence and foetomaternal outcome of Rh negative women during pregnancy.

Methods: In the study group, the labor was monitored carefully and the mode of delivery and the outcome of labor was studied in detail. Baby was thoroughly examined for any obvious congenital anomaly, weight, sex and condition was also noted particularly for hydrops. If neonate was Rh positive, then the mother was given postpartum immunoprophylaxis within 24 hours of delivery. The new born were followed for 3 days and were watched for the development of Jaundice. Mothers were advised to attend postnatal clinic for check-up after 6 weeks of delivery.

Results: Blood group distribution of newborn: 37 were Rh positive and 18 were Rh negative. Raised Rh antibody titre was not found in any of the 55 cases. Maximum cases 47 delivered at 38-40 weeks, 2 cases delivered after 40 weeks and 6 patients delivered between 30-38 weeks. Maximum cases 37 delivered normally, 12 required cesarean section and 2 had forceps delivery. The babies who developed NNHB were managed either by sunrays exposure only or by phototherapy. The babies who had anemia immediately after birth were carefully monitored and considered for exchange transfusion.

Conclusions: Tremendous advances in the medical services and technology during the last few decades have revolutionized the treatment of Rh disease. Various studies have been conducted and several are going on the in this field to achieve zero incidence of this disease.


Levine P. The influence of the ABO system on Rh hemolytic disease. Human Biol. 1958 Feb 1;30(1):14.

Freda VJ, Gorman JG, Pollack W, Robertson JG, Jennings ER, Sullivan JF. Prevention of Rh isoimmunization: progress report of the clinical trial in mothers. Jama. 1967 Feb 6;199(6):390-4.

Levine P. Serological factors as possible causes in spontaneous abortions. In: Rhesushaemolytic disease. Springer, Dordrecht; 1943:75-77.

Izetbegovic S. Occurrence of ABO and RhD incompatibility with Rh negative mothers. Materia Socio-medica. 2013 Dec;25(4):255.

Bujandrić N, Krga-Milanović M. The importance of immunohematology testing in the neonatal period. Medicinskipregled. 2013;66(7-8):317-21.

Taylor JF. Sensitization of Rh-negative daughters by their Rh-positive mothers. New England J Med. 1967 Mar 9;276(10):547-51.

Wiener AS. A new test (blocking test) for Rh sensitization. In: Rhesushaemolytic disease. Springer, Dordrecht; 1944:81-85.

Owen RD, Wood HR, Foord AG, Sturgeon P, Baldwin LG. Evidence for actively acquired tolerance to Rh antigens. Proceed Nat Acad Sci. 1954 Jun 1;40(6):420-4.

Clarke CA. Prevention of Rh-haemolytic disease. In: Rhesushaemolytic disease. Springer, Dordrecht; 1967:267-269.

Renkonen KO, Timonen S. Factors influencing the immunization of Rh-negative mothers. J Med Genet. 1967 Sep;4(3):166.

Altuntas N, Yenicesu İ, Himmetoglu Ö, Kulali F, Kazanci E, Unal S, et al. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey. Transfus Apheresis Sci. 2013 Jun 1;48(3):377-80.

Alvey JP. Obstetrical management of Rh incompatibility based on liquor amnii studies. Am J Obstet Gynecol. 1964 Nov 15;90(6):769-75.

Fung KK, Eason E, Crane J, Armson A, De SL, Farine D, et al. Prevention of Rh alloimmunization. Journal of obstetrics and gynaecology Canada. JOGC. 2003 Sep;25(9):765-73.

Kristinsdottir T, Kjartansson S, Hardardottir H, Jonsson T, Halldorsdottir AM. Positive Coomb's test in newborns; causes and clinical consequences summary of cases diagnosed in the blood bank in the years 2005 to 2012. Laeknabladid. 2016 Jul;102(7-8):326-31.






Original Research Articles